Supply Chain Intelligence

Nuo Therapeutics, Inc. Supply Chain

AURX supply chain intelligence for Nuo Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

AURX ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

8Suppliers
8Customers
2Debt Items
20Related Chains

Nuo Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
PAUL-ANTHONY-JACOBS PAUL-ANTHONY-JACOBS 90% Mr. Jacobs loaned $300,000 in the Initial Funding and did not commit to loaning additional funds in a Second Funding.
PFE Pfizer Inc. 90% Reciprocal relationship from PFE graph: Reciprocal relationship from AURX graph: a reagent, bovine thrombin, is available exclusively through Pfizer, with whom we have an existing supply agreement
PFE Pfizer Inc. 90% a reagent, bovine thrombin, is available exclusively through Pfizer, with whom we have an existing supply agreement
SCOTT-M-PITTMAN SCOTT-M-PITTMAN 90% Mr. Pittman loaned $200,000 in the Initial Funding and committed to loaning $210,000 in a Second Funding, if any.
AN-AFFILIATE-OF-AN-EXISTING-DISTRIBUTOR-OF-THE-C AN-AFFILIATE-OF-AN-EXISTING-DISTRIBUTOR-OF-THE-C 80% The other Lenders consist of an affiliate of an existing distributor of the Company's Aurix product and a third party unaffiliated with the Company.
CONTRACT-MANUFACTURERS CONTRACT-MANUFACTURERS 80% We outsource the manufacturing of various product components to contract manufacturers
SNNUF Smith & Nephew plc 72% quity capital was accessed in December 2021 via the early exercise of warrants under a warrant modification agreement. Distribution Agreement with Smith+Nephew On March 31, 2025, we entered into a Di…
SNNUF Smith & Nephew plc 72% Reciprocal relationship from SNNUF graph: Reciprocal relationship from AURX graph: quity capital was accessed in December 2021 via the early exercise of warrants under a warrant modification agreemen…

Nuo Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
AN-AFFILIATE-OF-AN-EXISTING-DISTRIBUTOR-OF-THE-C AN-AFFILIATE-OF-AN-EXISTING-DISTRIBUTOR-OF-THE-C 90% The other Lenders consist of an affiliate of an existing distributor of the Company's Aurix product
CUSTOMER-A CUSTOMER-A 90% Customer A 19 % - Customer B * 18 % Customer C * 15 % Customer D * 12 %
CUSTOMER-B CUSTOMER-B 90% Customer A 19 % - Customer B * 18 % Customer C * 15 % Customer D * 12 %
CUSTOMER-C CUSTOMER-C 90% Customer A 19 % - Customer B * 18 % Customer C * 15 % Customer D * 12 %
CUSTOMER-D CUSTOMER-D 90% Customer A 19 % - Customer B * 18 % Customer C * 15 % Customer D * 12 %
NEPHEW-PLC NEPHEW-PLC 85% in private office settings while continuing to engage with hospitals and hospital systems regarding expanded POS 22 usage while ensuring that the reimbursement mechanisms are appropriately administer…
SNNUF Smith & Nephew plc 85% quity capital was accessed in December 2021 via the early exercise of warrants under a warrant modification agreement. Distribution Agreement with Smith+Nephew On March 31, 2025, we entered into a Di…
SNNUF Smith & Nephew plc 85% Reciprocal relationship from SNNUF graph: Reciprocal relationship from AURX graph: Reciprocal relationship from SNNUF graph: Reciprocal relationship from AURX graph: Reciprocal relationship from SNNU…

Nuo Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
AURX-DEBT-7982 Warrants outstanding: 6363638 90% xbrl warrant detail from xbrl 2025-12-31.
AURX-DEBT-7983 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

Nuo Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Nuo Therapeutics, Inc..

Nuo Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
AURX-OWNER-ANCORA-ADVISORS-LLC Ancora Advisors LLC 90% 13F overlay lists Ancora Advisors LLC as top holder; 1 tracked holders.

Nuo Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
EW Edwards Lifesciences Corporation 100.00 2
CUPR Cuprina Holdings (Cayman) Limited 100.00 2
DEO Diageo plc 100.00 2
IHG InterContinental Hotels Group PLC 100.00 2
IART Integra LifeSciences Holdings Corporation 100.00 2
JNJ Johnson & Johnson 100.00 2
PFE Pfizer Inc. 100.00 1 ['supplier']
MDWD MediWound Ltd. 100.00 2
RLAY Relay Therapeutics, Inc. 50.00 2
SPRO Spero Therapeutics, Inc. 50.00 2
HBIO Harvard Bioscience, Inc. 50.00 2
ESPR Esperion Therapeutics, Inc. 50.00 2
ITGR Integer Holdings Corporation 50.00 2
NVAX Novavax, Inc. 50.00 2
CELC Celcuity Inc. 50.00 2
NRIX Nurix Therapeutics, Inc. 50.00 2
MDXG MiMedx Group, Inc. 50.00 2
ITRM Iterum Therapeutics PLC 50.00 2
SNWV SANUWAVE Health, Inc. 50.00 2
PYXS Pyxis Oncology, Inc. 50.00 2
View AURX supply chain intel →

Explore the full interactive supply chain map for Nuo Therapeutics, Inc..

Open AURX supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map